InBioGen Co Stock

InBioGen Co Debt

The Debt of InBioGen Co (101140.KS) as of Sep 5, 2026 is 894.79 M KRW. In the previous year, Debt was 593.26 M KRW — a change of 50.82% (higher).

Debt

894.79 MKRW

YoY

50.82%

Last updated:

In 2026, InBioGen Co's total debt was 894.79 M KRW, a 50.82% change from the 593.26 M KRW total debt recorded in the previous year.

The InBioGen Co Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2017
358.00 M KRW
Jan 1, 2018
0.00 KRW
Jan 1, 2019
9.88 B KRW
Jan 1, 2020
4.77 B KRW
Jan 1, 2021
63.34 B KRW
Jan 1, 2022
34.33 B KRW
Jan 1, 2023
593.26 M KRW
Jan 1, 2024
894.79 M KRW
The InBioGen Co Debt history
YEARDebtYoY
894.79 MKRW+50.82%
593.26 MKRW-98.27%
34.33 BKRW-45.81%
63.34 BKRW+1,227.63%
4.77 BKRW-51.71%
9.88 BKRW—
0.00KRW-100.00%
358.00 MKRW-86.08%
2.57 BKRW-8.54%
2.81 BKRW+131.17%
1.22 BKRW—
Access this data via the Eulerpool API
Get Free API Key

InBioGen Co Stock analysis

What does InBioGen Co do? InBioGen Co is one of the most popular companies on Eulerpool.

Debt Details

Understanding InBioGen Co's Debt Structure

InBioGen Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing InBioGen Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to InBioGen Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in InBioGen Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about InBioGen Co stock

Debt of InBioGen Co is 894.79 M KRW in 2026.

Debt of InBioGen Co changed from 593.26 M KRW to 894.79 M KRW, representing a 50.82% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt InBioGen Co since 2006 – with annual values, charts, and detailed analysis.

Debt's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's InBioGen Co historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — InBioGen Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — InBioGen Co